Table 3.
Treatment effects on plasma
| Female | Male | |||||
|---|---|---|---|---|---|---|
|
| ||||||
| Nc | Gr | Hx | Nc | Gr | Hx | |
|
| ||||||
| Monocytes (K μL−1) | 0.38±0.08 | 0.20±.011 | 0.23±0.06 | 0.34±0.11 | 0.27±0.11 | 0.90±0.30*§ |
|
|
||||||
| Neutrophils (K μL−1) | 1.35±0.25 | 0.76±0.18 | 0.77±0.12 | 1.45±0.39 | 1.08±0.31 | 2.68±0.53*§ |
|
|
||||||
| TNFα (pg ml−1) | 2.56±0.23 | 3.05±0.13 | 3.86±0.27* | 2.68±0.15 | 2.91±0.10 | 3.96±0.25*§ |
|
|
||||||
| IL-6 (pg ml−1) | 14.0±1.5 | 16.0±2.8 | 27.2±2.0*§ | 13.5±1.5 | 18.7±1.6 | 30.2±3.7*§ |
|
|
||||||
| Hemoglobin (g.dL−1) | 12.1±0.4 | 12.6±0.2* | 13.4±0.1*§ | 13.5±0.1 | 15.1±0.2* | 16.0±0.2*§ |
|
|
||||||
| Testosterone (ng ml−1) | 1.58±0.22 | 1.07±0.11 | 0.82±0.09* | 1.52±0.14 | 1.12±0.08 | 0.95±0.35 |
|
|
||||||
| Estradiol (pg ml−1) | 40.3±3.8 | 37.0±2.7 | 40.0±8.0 | 30.2±2.5 | 42.1±2.4* | 47.4±12.0 |
n ≥ 7,
*
P<0.05 vs. Nc;
§
P<0.05 vs. Gr.